Amyloid-β peptide (Aβ) oligomers are characteristic symptom of Alzheimer's disease (AD).
The development of powerful methods for arresting specific Aβ oligomers remains to be a …

Amyloid‐β peptide (Aβ) oligomers, characteristic symptom of Alzheimer's disease (AD), have
been identified as the most neurotoxic species and significant contributors to …

A major hallmark of Alzheimer's disease is the misfolding and aggregation of the amyloid-β
peptide (Aβ). While early research pointed towards large fibrillar-and plaque-like aggregates …

Photoinduced cross-linking (PIC) has become a powerful tool in chemical biology for the
identification and mapping of stable or transient interactions between biomacromolecules …

The assembly of the amyloid β-protein (Aβ) into neurotoxic oligomers and fibrils is a seminal
pathogenic process in Alzheimer's disease (AD). Understanding the mechanisms of Aβ …

Preventing and treating Alzheimer's disease require understanding the aggregation of
amyloid beta 1–42 (Aβ1–42) to give oligomers, protofibrils, and fibrils. Here we describe …

A major hallmark of Alzheimer's disease is the misfolding and aggregation of the amyloid-β
(Aβ) peptide into β-sheet-rich fibrils. Emerging evidence now implicates small oligomeric …

There is growing demand for novel methods that could render the controlled disassembly of
higher-order structures formed, for example, by peptides. Herein, we demonstrate such a …

A combination of time-resolved optical spectroscopy and nanoscale imaging has been used
to study the complex binding to amyloids of a photocatalyst that selectively photo …

Misfolded amyloid-β (Aβ) is the key biomarker of Alzheimer's disease (AD), and discoveries
of fluorescence chemicals visualizing such Aβ aggregates in the brain have made major …